MedTrace Logo

A Trial of Taurine Supplementation in Parenteral Nutrition 1

NCT00135044 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2007-09-24

No results posted yet for this study

Summary

The purpose of this study is to investigate whether the inclusion of 1g of intravenous taurine as part of the nitrogen source of parenteral nutrition reduces parenteral nutrition associated cholestatic liver disease, a common side effect of parenteral nutrition.

Conditions

  • Cholestasis

Interventions

PROCEDURE

intravenous taurine in nutritional supplement

Sponsors & Collaborators

  • Fresenius AG

    collaborator INDUSTRY

  • London North West Healthcare NHS Trust

    lead OTHER

Principal Investigators

  • Simon Gabe, MD · North West London NHS Trust - St Mark's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30

Countries

  • United Kingdom

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00135044 on ClinicalTrials.gov